Nebion G was acquired by Immunai, in 2021. Immunai has curated hundreds of thousands of samples and millions of cells across thousands of public studies under a unified clinical ontology.
With GENEVESTIGATOR, we provide researchers an advanced platform for exciting discoveries in academia and industry.